Gain Therapeutics Inc.
GANX | NASDAQ
$1.95
+$0.11 (+5.98%)
At close: Sep 22, 2026, 4:00 PM ET
$1.92
-$0.03 (-1.73%)
After-hours:
Sep 22, 2026, 5:15 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 20.84M | 10.39M | 11.79M | 7.31M | 36.88M | 7.49M |
Short-Term Investments | n/a | n/a | 5M | 12.83M | n/a | n/a |
Long-Term Investments | 36.3K | 31.7K | 34.02K | 1.94M | 31.28K | n/a |
Other Long-Term Assets | 33.7K | 32.11K | 17.89K | 48.32K | 53.39K | 63.82K |
Receivables | 802.69K | 765.76K | 242.58K | 103.88K | 195.45K | 8.55K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 275.43K | 369.89K | n/a | 640.31K | n/a | 1.29M |
Total Current Assets | 22.24M | 11.6M | 17.78M | 21.09M | 37.72M | 8.99M |
Property-Plant & Equipment | 409.01K | 323.33K | 585.18K | 804.31K | 1.01M | 552.71K |
Goodwill & Intangibles | 102.84K | 134.27K | 193.38K | 213.97K | 202.61K | n/a |
Total Long-Term Assets | 581.84K | 521.41K | 830.46K | 3.01M | 1.26M | 616.53K |
Total Assets | 22.82M | 12.12M | 18.61M | 24.1M | 38.99M | 9.6M |
Account Payables | 825.03K | 946.26K | 1.32M | 1.63M | 560.48K | 961.52K |
Deferred Revenue | n/a | 252.21K | 1.12M | 55.18K | 266.5K | n/a |
Short-Term Debt | 100.87K | 110.18K | 118.8K | 108.14K | 103.83K | 22.63K |
Other Current Liabilities | 167.89K | 18.49K | 1.38M | 364.11K | 380 | 245.86K |
Total Current Liabilities | 3.35M | 3.91M | 4.95M | 4.13M | 2.55M | 2.11M |
Long-Term Debt | 300.08K | 328.33K | 449.05K | 495.26K | 590.47K | 715.66K |
Other Long-Term Liabilities | 390.51K | 443.62K | 307.45K | 157.58K | 329.46K | 171.56K |
Total Long-Term Liabilities | 901.83K | 872.99K | 1.08M | 1.09M | 1.61M | 1.29M |
Total Liabilities | 4.25M | 4.78M | 6.03M | 5.22M | 4.17M | 3.4M |
Total Debt | 732.07K | 653.02K | 1.03M | 1.27M | 1.61M | 1.26M |
Book Value | 18.56M | 7.34M | 12.58M | 18.88M | 34.82M | 6.2M |
Book Value Per Share | 0.56 | 0.32 | 0.97 | 1.59 | 3.43 | 0.52 |
Common Stock | 4.21K | 2.71K | 1.62K | 1.19K | 1.19K | 354 |
Retained Earnings | -101.36M | -81.19M | -60.78M | -38.52M | -20.93M | -7.03M |
Comprehensive Income | 776.87K | -247.55K | 247.24K | 35.63K | -90.65K | -152.7K |
Shareholders Equity | 18.56M | 7.34M | 12.58M | 18.88M | 34.82M | 6.2M |
Total Investments | 36.3K | 31.7K | 5.03M | 14.77M | 31.28K | n/a |
Add to Watchlist
Select watchlists to add or remove GANX